Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
387 questions in 55 reviews · Common Mental Disorders
current versionsNo studies 387 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Change in hospital admission rates · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Attempted suicide · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Attempted suicide · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Study withdrawal · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in hospital admission rates · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cost‐effectiveness of interventions · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Study withdrawal · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in hospital admission rates · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cost‐effectiveness of interventions · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Attempted suicide · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Study withdrawal · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in hospital admission rates · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs psychological treatment Pain intensity End of treatment · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs psychological treatment Quality of Life (QoL) · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs psychological treatment Depression · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs psychological treatment Sleep · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs adaptive pacing therapy Pain End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs adaptive pacing therapy Quality of Life (QOL) End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs adaptive pacing therapy Depression Measured at end of treatment · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs adaptive pacing therapy Sleep Measured at end of treatment · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs antidepressants Fatigue Long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs control Pain Measured at end of treatment · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs antidepressants Serious adverse reactions End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs antidepressants Pain End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs antidepressants Physical functioning End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs antidepressants Qualityof Life (QOL) End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs antidepressants Depression Long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs antidepressants Sleep End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy plus antidepressants vs antidepressants alone Fatigue Long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy plus antidepressants vs antidepressants alone Serious adverse reactions End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy plus antidepressants vs antidepressants alone Pain End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy plus antidepressants vs antidepressants alone Physical functioning End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy plus antidepressants vs antidepressants alone Quality of Life (QOL) End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy plus antidepressants vs antidepressants alone Depression Long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy plus antidepressants vs antidepressants alone Sleep End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs control Quality of Life (QoL) Measured at end of treatment · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs lamotrigine Efficacy: response (categorical) YMRS/SADS‐C decrease ≥ 50% by end of study · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs lamotrigine Efficacy: remission (categorical) YMRS ≤ 12 and no increase in MADRS at end of study · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs carbamazepine Efficacy: response (categorical) YMRS/SADS‐C decrease ≥ 50% by end of study · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs carbamazepine Efficacy: remission (categorical) YMRS ≤ 12 and no increase in MADRS at end of study · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs quetiapine Adverse events · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs olanzapine Adverse events · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs chlorpromazine Efficacy: response (categorical) MSRS/YMRS ≥ 50% decrease in score by end of study · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs chlorpromazine Efficacy: remission (categorical) YMRS ≤ 12 at end of study · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs chlorpromazine Adverse events · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs haloperidol Efficacy: response (categorical) MSRS/YMRS ≥ 50% decrease in score by end of study · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs haloperidol Efficacy: remission (categorical) YMRS ≤ 12 at end of study · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs haloperidol Adverse events · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs zuclopenthixol Efficacy: response (continuous) change in BPRS (total) from baseline to end of study ‐all data · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |
Lithium vs zuclopenthixol Efficacy: remission (categorical) YMRS ≤ 12 at end of study · acute mania Lithium for acute mania (2019) · Cochrane | no estimate extracted | NR | No studies |